Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484455 · ClinicalTrials.gov registry record · NA
Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant
A NA study, sponsored by Organ Recovery Systems.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03484455: Completed NA study, sponsored by Organ Recovery Systems.
NCT03484455 is a NA study that has completed, run by Organ Recovery Systems. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03484455, a NA study, has completed, sponsored by Organ Recovery Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
Comparison of hypothermic machine perfusion of livers to standard of care (static cold storage).
Primary Outcome
EAD defined as total bilirubin ≥ 10 mg/dL or International Normalized Ratio (INR) ≥ 1.6 or Aspartate Aminotransferase (AST) \>2000IU/L or Alanine Aminotransferase (ALT) \> 2000 IU/L
Interventions
- DEVICE Hypothermic machine perfusion
- DEVICE Static cold storage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2022-07-12 |
| Phase | NA |
What the finished NCT03484455 record still lists
NCT03484455 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Hypothermic machine perfusion is the first listed.
NCT03484455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03484455 about?
NCT03484455 is a clinical study titled "Study to Evaluate Performance of the Organ Recovery Systems LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant". Comparison of hypothermic machine perfusion of livers to standard of care (static cold storage).
What is the current status of trial NCT03484455?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2019-04-03. Estimated completion is 2022-07-12.
What interventions are being tested in trial NCT03484455?
The interventions under investigation include: Hypothermic machine perfusion (DEVICE), Static cold storage (DEVICE).
Who is sponsoring clinical trial NCT03484455?
This trial is sponsored by Organ Recovery Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03484455's enrollment target sits among peer trials
142 711th of 2000 higher than 1,289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI